Solid Tumors and Hematologic Malignancy
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14776 | Camrelizumab | 1 | Completed | 1 |
| DB11717 | Epacadostat | 1 | Completed | 1 |
| DB15102 | Pemigatinib | 1 | Recruiting | 1 |
| DB05812 | Abiraterone | 1 / 2 | Terminated | 1 |
| DB00928 | Azacitidine | 1 / 2 | Recruiting | 2 |
| DB00928 | Azacitidine | 1 / 2 | Terminated | 1 |
| DB00515 | Cisplatin | 1 / 2 | Recruiting | 1 |
| DB00987 | Cytarabine | 1 / 2 | Recruiting | 1 |
| DB01248 | Docetaxel | 1 / 2 | Recruiting | 1 |
| DB11714 | Durvalumab | 1 / 2 | Completed | 1 |
| DB11717 | Epacadostat | 1 / 2 | Active Not Recruiting | 1 |
| DB11717 | Epacadostat | 1 / 2 | Completed | 1 |
| DB00441 | Gemcitabine | 1 / 2 | Recruiting | 1 |
| DB00441 | Gemcitabine | 1 / 2 | Terminated | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 / 2 | Terminated | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB15102 | Pemigatinib | 1 / 2 | Recruiting | 1 |
| DB12332 | Rucaparib | 1 / 2 | Terminated | 1 |
| DB08877 | Ruxolitinib | 1 / 2 | Recruiting | 1 |
| DB08877 | Ruxolitinib | 1 / 2 | Terminated | 1 |
| DB00072 | Trastuzumab | 1 / 2 | Recruiting | 1 |
| DB00755 | Tretinoin | 1 / 2 | Recruiting | 1 |
| DB00530 | Erlotinib | 2 | Withdrawn | 1 |
| DB12154 | Itacitinib | 2 | Withdrawn | 1 |